Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fatal leukemia in interleukin-15 transgenic mice.
Fehniger TA, Suzuki K, VanDeusen JB, Cooper MA, Freud AG, Caligiuri MA. Fehniger TA, et al. Among authors: caligiuri ma. Blood Cells Mol Dis. 2001 Jan-Feb;27(1):223-30. doi: 10.1006/bcmd.2001.0379. Blood Cells Mol Dis. 2001. PMID: 11358383 Review.
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, Carroll AJ, Mrózek K, Vardiman JW, George SL, Kolitz JE, Larson RA, Bloomfield CD, Caligiuri MA. Whitman SP, et al. Among authors: caligiuri ma. Cancer Res. 2001 Oct 1;61(19):7233-9. Cancer Res. 2001. PMID: 11585760
Interleukin-2 and interleukin-15: immunotherapy for cancer.
Fehniger TA, Cooper MA, Caligiuri MA. Fehniger TA, et al. Among authors: caligiuri ma. Cytokine Growth Factor Rev. 2002 Apr;13(2):169-83. doi: 10.1016/s1359-6101(01)00021-1. Cytokine Growth Factor Rev. 2002. PMID: 11900992 Review.
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
Farag SS, George SL, Lee EJ, Baer M, Dodge RK, Becknell B, Fehniger TA, Silverman LR, Crawford J, Bloomfield CD, Larson RA, Schiffer CA, Caligiuri MA. Farag SS, et al. Among authors: caligiuri ma. Clin Cancer Res. 2002 Sep;8(9):2812-9. Clin Cancer Res. 2002. PMID: 12231521 Clinical Trial.
484 results